未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial靶向B7H3抗体药物偶联物在晚期实体瘤中的研究：一项1/1b期临床试验
Ma, Yuxiang; Yang, Yunpeng; Huang, Yan; Fang, Wenfeng; Xue, Jinhui; Meng, Xiangjiao; Fu, Siqing; Zheng, Yulong; Liu, Jian; Liu, Zhihua; Zhuang, Wu; Rosen, Seth; Qu, Song; Li, Bihui; Li, Mingjun; Zhao, Yanqiu; Yang, Shujun; Ji, Yinghua; Sommerhalder, David; Luo, Suxia; Yang, Kunyu; Li, Jingao; Lv, Dongqing; Zhang, Peng; Zhao, Yuanyuan; Hong, Shaodong; Zhang, Yang; Zhao, Shen; Chin, Steve; Zhang, Xian; Lian, Wei; Cai, Jiaqiang; Xue, Tongtong 分享 收藏 S1P/S1PRs-TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitisZhang, Xinyu; Zhou, Yuan; Wang, Changming; Ren, Jiahui; Wang, Yin; Liu, Pei; Feng, Weimeng; Li, Xue; Qi, Mingxin; Yang, Yan; Zhu, Chan; Wang, Fang; Ma, Yuxiang; Tang, Zongxiang; Yu, Guang 分享 收藏 Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective studyLiu, Jiaqing; Sun, Dongchen; Xu, Shuoyu; Shen, Jiayi; Ma, Wenjuan; Zhou, Huaqiang; Ma, Yuxiang; Zhang, Yaxiong; Fang, Wenfeng; Zhao, Yuanyuan; Hong, Shaodong; Zhan, Jianhua; Hou, Xue; Zhao, Hongyun; Huang, Yan; He, Bingdou; Yang, Yunpeng; Zhang, Li 分享 收藏 Oroxylin A attenuates psoriasiform skin inflammation by direct targeting p62 (sequestosome 1) via suppressing M1 macrophage polarizationMa, Yuxiang; Liu, Yunyao; Zhong, You; Li, Xiangzheng; Xu, Yujiao; Chen, Leyi; Gong, Litong; Huang, He; Chen, Xu; He, Yuan; Qiang, Lei 分享 收藏 YL201, a novel B7H3-targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors: Results from a first-in-human phase I studyYL201，一种新型的B7H3靶向抗体药物偶联物（ADC），在晚期实体瘤患者（pts）中的研究：来自一项首次人体I期研究的结果Zhao, H.; Ma, Y.; Meng, X.; Wu, L.; Fan, Y.; Zheng, Y.; Liu, Z.; Ji, Y.; Lv, D.; Luo, S.; Sommerhalder, D.; Fu, S.; Huang, Y.; Yang, Y.; Fang, W.; Zhao, Y.; Wang, Y.; Chin, S.; Xue, T.; Zhang, L. 分享 收藏 Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinomaMa, Yuxiang; Zhou, Huaqiang; Luo, Fan; Zhang, Yang; Zhu, Changbin; Li, Weiwei; Huang, Zhan; Zhao, Jingbo; Xue, Jinhui; Zhao, Yuanyuan; Fang, Wenfeng; Yang, Yunpeng; Huang, Yan; Zhang, Li; Zhao, Hongyun 分享 收藏 Preclinical characterization and phase 1 results of ADG106 in patients with advanced solid tumors and non-Hodgkin's lymphomaADG106在晚期实体瘤和非霍奇金淋巴瘤患者中的临床前特征和1期结果Ma, Yuxiang; Luo, Fan; Zhang, Yang; Liu, Qianwen; Xue, Jinhui; Huang, Yan; Zhao, Yuanyuan; Yang, Yunpeng; Fang, Wenfeng; Zhou, Ting; Chen, Gang; Cao, Jiaxin; Chen, Qun; She, Xiaohong; Luo, Peter; Liu, Guizhong; Zhang, Li; Zhao, Hongyun 分享 收藏 Macrophage autophagy deficiency-induced CEBPB accumulation alleviates atopic dermatitis via impairing M2 polarization巨噬细胞自噬缺乏诱导的CEBPB积累通过损害M2极化减轻特应性皮炎Zhu, Yongcheng; Liu, Yunyao; Ma, Yuxiang; Tan, Cheng; He, Yuan; Qiang, Lei; Chen, Liu; Huang, He; Huang, Siting; Zhang, Huiling; He, Yuying 分享 收藏 分享 收藏 A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapyChen, Zude; Yang, Xiaoshuang; Chen, Zugen; Li, Minzhao; Wang, Wei; Yang, Riwei; Wang, Zuomin; Ma, Yuxiang; Xu, Yulong; Ao, Shan; Liang, Leqi; Cai, Chao; Wang, Changning; Deng, Tuo; Gu, Di; Zhou, Hongqing; Zeng, Guohua 分享 收藏 BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate, in patients with non-small cell lung cancer: Updated results from first-in-human phase I studyZhang, L.; Ma, Y.; Zhao, Y.; Fang, W. F.; Zhao, H.; Huang, Y.; Yang, Y.; Hou, X.; Wen, Z.; Zhang, S.; Wang, J.; Xiao, S.; Wang, H.; Zhu, H.; Olivo, M. S.; Zhu, Y. 分享 收藏 Randomized phase II adjuvant trial to compare two treatment durations of icotinib (2 years versus 1 year) for stage II-IIIA EGFR-positive lung adenocarcinoma patients (ICOMPARE study)Lv, C.; Wang, R.; Li, S.; Yan, S.; Wang, Y.; Chen, J.; Wang, L.; Liu, Y.; Guo, Z.; Wang, J.; Pei, Y.; Yu, L.; Wu, N.; Lu, F.; Gao, F.; Chen, J.; Liu, Y.; Wang, X.; Li, S.; Han, B.; Zhang, L.; Ma, Y.; Ding, L.; Wang, Y.; Yuan, X.; Yang, Y. 分享 收藏 First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors双功能PD1/CTLA4双重阻滞剂QL1706 (PSB205) 在晚期实体瘤患者中的首次人体I/Ib期研究Zhao, Yuanyuan; Ma, Yuxiang; Zang, Aimin; Cheng, Ying; Zhang, Yiping; Wang, Xiangcai; Chen, Zhendong; Qu, Song; He, Jianbo; Chen, Chuanben; Jin, Chuan; Zhu, Dongyuan; Li, Qingshan; Liu, Xianling; Su, Wuyun; Ba, Yi; Hao, Yanrong; Chen, Junmin; Zhang, Guoping; Qu, Shenhong; Li, Yong; Feng, Weineng; Yang, Mengxiang; Liu, Baorui; Ouyang, Weiwei; Liang, Jin; Yu, Zhuang; Kang, Xiaoyan; Xue, Shilin; Yang, Guihong; Yan, Wei; Yang, Yingying; Liu, Zhi; Peng, Yufeng; Fanslow, Bill; Huang, Xian; Zhang, Li; Zhao, Hongyun 分享 收藏 分享 收藏 Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumorsMa, Yu-Xiang; Liu, Fu-Rong; Zhang, Yang; Chen, Qun; Chen, Zhi-Qiang; Liu, Qian-Wen; Huang, Yan; Yang, Yun-Peng; Fang, Wen-Feng; Xi, Ning; Kang, Ning; Zhuang, Yu-Lei; Zhang, Qi; Jiang, Ying-Zhi; Zhang, Li; Zhao, Hong-Yun 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
Annals of Oncology.png)
